These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7488865)

  • 1. Establishment and characterization of an antihuman thyrotropin (TSH) receptor-specific CD4+ T cell line from a patient with Graves' disease: evidence for multiple T cell epitopes on the TSH receptor including the transmembrane domain.
    Akamizu T; Ueda Y; Hua L; Okuda J; Mori T
    Thyroid; 1995 Aug; 5(4):259-64. PubMed ID: 7488865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain.
    Soliman M; Kaplan E; Yanagawa T; Hidaka Y; Fisfalen ME; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Mar; 80(3):905-14. PubMed ID: 7533773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR vbeta usage of TSH receptor-specific CD4+ T cells in Graves' disease patients and healthy humans.
    Raju R; Navaneetham D; Kellermann SA; Freeman SL; Morris JC; McCormick DJ; Conti-Fine BM
    J Autoimmun; 1997 Oct; 10(5):479-89. PubMed ID: 9376076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptides epitopes of human thyrotropin receptor.
    Okamoto Y; Yanagawa T; Fisfalen ME; DeGroot LJ
    Thyroid; 1994; 4(1):37-42. PubMed ID: 7519915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease.
    Inaba H; Martin W; De Groot AS; Qin S; De Groot LJ
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2286-94. PubMed ID: 16595602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls.
    Kellermann SA; McCormick DJ; Freeman SL; Morris JC; Conti-Fine BM
    J Autoimmun; 1995 Oct; 8(5):685-98. PubMed ID: 8579724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves' disease.
    Martin A; Nakashima M; Zhou A; Aronson D; Werner AJ; Davies TF
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3361-6. PubMed ID: 9329369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in cellular and antibody responses against thyrotropin receptor in patients with Graves' disease detected using synthetic peptides.
    Fan JL; Desai RK; Seetharamaiah GS; Dallas JS; Wagle NM; Prabhakar BS
    J Autoimmun; 1993 Dec; 6(6):799-808. PubMed ID: 7512341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of T-cell lines responsive to immunodominant epitopes of thyrotropin receptor in healthy subjects.
    Molteni M; Zulian C; Scrofani S; Della Bella S; Bonara P; Kohn LD; Scorza R
    Thyroid; 1998 Mar; 8(3):241-7. PubMed ID: 9545111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism.
    Pichurin P; Pham N; David CS; Rapoport B; McLachlan SM
    Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes.
    Mukuta T; Yoshikawa N; Arreaza G; Resetkova E; Leushner J; Song YH; Akasu F; Onaya T; Volpé R
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1264-72. PubMed ID: 7714099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the peptides that inhibit the stimulation of thyrotropin receptor by Graves' immunoglobulin G from peptide libraries.
    Park JY; Kim IJ; Lee MH; Seo JK; Suh PG; Cho BY; Ryu SH; Chae CB
    Endocrinology; 1997 Feb; 138(2):617-26. PubMed ID: 9002995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of heterogeneous thyroid-stimulating antibodies in sera from individual Graves' patients as shown by synthesized thyrotropin receptor peptide application: evidence showing two independent epitopes and a possible recognition of two epitopic regions by one antibody molecule.
    Sugawa H; Akamizu T; Kosugi S; Ueda Y; Ohta C; Okuda J; Mori T
    Eur J Endocrinol; 1995 Sep; 133(3):283-93. PubMed ID: 7581943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide scanning for thyrotropin receptor T-cell epitopes in mice vaccinated with naked DNA.
    Pichurin P; Schwarz-Lauer L; Braley-Mullen H; Paras C; Pichurina O; Morris JC; Rapoport B; McLachlan SM
    Thyroid; 2002 Sep; 12(9):755-64. PubMed ID: 12481940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.
    Li CW; Osman R; Menconi F; Concepcion E; Tomer Y
    J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that factors other than particular thyrotropin receptor T cell epitopes contribute to the development of hyperthyroidism in murine Graves' disease.
    Pichurin PN; Chen CR; Nagayama Y; Pichurina O; Rapoport B; McLachlan SM
    Clin Exp Immunol; 2004 Mar; 135(3):391-7. PubMed ID: 15008970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of autoantibody reactivity in patients with Graves' disease using recombinant extracellular domain of the human thyrotropin receptor and synthetic peptides.
    Fan JL; Seetharamaiah GS; Desai RK; Dallas JS; Wagle NM; Prabhakar BS
    Autoimmunity; 1993; 15(4):285-91. PubMed ID: 8136456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.